Mucosal Immunopathogenesis of Francisella tularensis
- 1 June 2007
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1105 (1) , 266-283
Abstract
Respiratory infection with Francisella tularensis is the deadliest form of disease and represents the most likely route to be used by bioterrorists. Although mucosal surfaces represent the first line of defense against respiratory tularemia, and in fact, against the great majority of human pathogens, little is known about protective immunity at these sites. The objective of this chapter is to review recent data examining the importance of various pulmonary immune mechanisms in defense against F. tularensis infection and to evaluate potential strategies for induction of protective lung immunity. Aerosol and intranasal mouse infection models have yielded essentially equivalent results and have implicated an important role for Th1-type immune responses in protection, including IFN-gamma, TNF-alpha, and IL-12. The cells responsible for protection in the lung are not well-characterized but NK cells are an early target for activation after infection although it appears that CD8 T cells might be most critical for host resistance. In addition, it is becoming increasingly clear that antibodies can provide prophylactic and therapeutic protection against pulmonary infection but only in the presence of active cell-mediated immunity. In fact, in vitro exposure of resting macrophages to antibody-coated bacteria in the absence of IFN-gamma can actually enhance infection. Although various immune mechanisms can be shown to be important for protection against attenuated strains such as LVS, the real challenge for the future is to design efficacious approaches to prevent disease by highly virulent strains such as SchuS4.Keywords
This publication has 38 references indexed in Scilit:
- InactivatedFrancisella tularensisLive Vaccine Strain Protects against Respiratory Tularemia by Intranasal Vaccination in an Immunoglobulin A-Dependent FashionInfection and Immunity, 2007
- Mouse Model of Oral Infection with Virulent Type A Francisella tularensisInfection and Immunity, 2007
- Francisella tularensis Replicates within Alveolar Type II Epithelial Cells In Vitro and In Vivo following InhalationInfection and Immunity, 2007
- Francisella tularensis LVS grown in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitroMicrobial Pathogenesis, 2006
- Superoxide Dismutase B Gene (sodB)-Deficient Mutants ofFrancisella tularensisDemonstrate Hypersensitivity to Oxidative Stress and Attenuated VirulenceJournal of Bacteriology, 2006
- Characterization of the Receptor-Ligand Pathways Important for Entry and Survival ofFrancisella tularensisin Human MacrophagesInfection and Immunity, 2006
- Pivotal Advance: Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escapeJournal of Leukocyte Biology, 2006
- Toll-Like Receptor 2 Is Required for Control of Pulmonary Infection withFrancisella tularensisInfection and Immunity, 2006
- Toll-Like Receptor 2 Is Required for Inflammatory Responses toFrancisella tularensisLVSInfection and Immunity, 2006
- Natural Killer and CD8 T Cells Dominate the Response by Human Peripheral Blood Mononuclear Cells to Inactivated Francisella tularensis Live Vaccine StrainHuman Immunology, 2005